tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

BioRestorative Therapies Inc

BRTX
Add to Watchlist
0.206USD
-0.020-8.78%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.24MMarket Cap
LossP/E TTM

BioRestorative Therapies Inc

0.206
-0.020-8.78%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BRTX Financials

See BioRestorative Therapies Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

BioRestorative Therapies Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.12/-0.20
Revenue / Forecast
23.17K/312.50K
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
359.70K
-10.30%
EPS(YoY)
-1.58
-36.93%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
80.98%-0.12
-63.45%-0.33
-147.99%-0.33
38.73%-0.30
-91.73%-0.64
-180.50%-0.20
-112.88%-0.13
66.24%-0.50
82.73%-0.33
121.07%0.25
--1.04
---1.47
---1.93
---1.19
---3.93
----
----
----
----
----
Revenue
-7.32%23.17K
-54.73%19.60K
-94.95%11.80K
240.40%303.30K
-28.57%25.00K
124.35%43.30K
660.91%233.60K
38.14%89.10K
11.82%35.00K
421.62%19.30K
5.86%30.70K
-9.28%64.50K
95.63%31.30K
-26.00%3.70K
262.50%29.00K
374.00%71.10K
-11.11%16.00K
-70.59%5.00K
-46.67%8.00K
-21.05%15.00K
Net Profit
59.65%-2.15M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
-239.54%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
126.97%1.17M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
-254.14%-20.40M
-400.35%-4.18M
-241.28%-4.06M
Net Margin
56.47%-9298.25%
-333.11%-16365.49%
-5410.97%-25748.11%
80.63%-875.79%
-236.25%-21359.20%
-162.20%-3778.63%
-103.01%-467.22%
48.92%-4521.39%
72.28%-6352.16%
105.17%6075.45%
--15531.79%
---8851.78%
---22915.57%
---117501.43%
---12185.37%
----
----
----
----
----
Gross Margin
-22.90%68.13%
-0.69%91.65%
-88.69%10.42%
4.75%97.12%
-11.64%88.36%
-7.71%92.29%
-7.81%92.19%
-7.28%92.72%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Income Statement
Revenue
-7.32%23.17K
-54.73%19.60K
-94.95%11.80K
240.40%303.30K
-28.57%25.00K
124.35%43.30K
660.91%233.60K
38.14%89.10K
11.82%35.00K
421.62%19.30K
5.86%30.70K
-9.28%64.50K
95.63%31.30K
-26.00%3.70K
262.50%29.00K
374.00%71.10K
-11.11%16.00K
-70.59%5.00K
-46.67%8.00K
-21.05%15.00K
Operating profit
29.57%-3.39M
-42.20%-3.83M
-62.18%-3.71M
-33.88%-3.31M
-16.99%-4.81M
16.47%-2.69M
26.33%-2.29M
20.78%-2.47M
28.89%-4.11M
31.21%-3.22M
32.65%-3.10M
32.67%-3.12M
-14.35%-5.78M
-16.78%-4.68M
-24.97%-4.61M
-30.19%-4.63M
66.43%-5.05M
-369.21%-4.01M
-504.44%-3.69M
-670.22%-3.56M
Net Profit
59.65%-2.15M
-96.05%-3.21M
-178.38%-3.04M
34.06%-2.66M
-140.18%-5.34M
-239.54%-1.64M
-122.89%-1.09M
29.44%-4.03M
69.00%-2.22M
126.97%1.17M
202.41%4.77M
-22.12%-5.71M
-48.93%-7.17M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
-254.14%-20.40M
-400.35%-4.18M
-241.28%-4.06M
Balance Sheet
Current assets
-59.38%3.80M
-71.85%3.14M
-65.15%4.71M
-49.36%7.60M
-44.21%9.36M
-2.16%11.14M
7.18%13.51M
24.58%15.00M
31.19%16.77M
-24.71%11.39M
-25.37%12.60M
-34.27%12.04M
-35.69%12.78M
-29.53%15.13M
1343.81%16.89M
901.96%18.32M
666.23%19.88M
573.61%21.47M
445.47%1.17M
431.39%1.83M
Total current liabilities
-61.39%1.61M
-0.68%3.72M
-25.01%3.44M
-30.99%3.67M
21.29%4.18M
43.76%3.75M
391.25%4.58M
554.46%5.32M
633.04%3.45M
492.17%2.61M
30.04%932.62K
30.73%812.85K
-4.75%470.39K
21.02%440.30K
-17.89%717.18K
-53.12%621.78K
-61.77%493.83K
-65.18%363.82K
-36.45%873.47K
50.46%1.33M
Total assets
-55.07%4.64M
-66.78%4.08M
-61.28%5.64M
-47.16%8.52M
-42.47%10.33M
-2.63%12.28M
5.60%14.57M
21.19%16.12M
27.49%17.95M
-23.26%12.61M
-22.99%13.80M
-31.59%13.30M
-32.69%14.08M
-26.81%16.43M
723.90%17.92M
573.92%19.44M
465.20%20.92M
416.52%22.45M
52.21%2.18M
78.83%2.88M
Total liabilities
-61.39%1.61M
-0.68%3.72M
-25.01%3.44M
-30.99%3.67M
21.29%4.18M
43.76%3.75M
369.89%4.58M
493.44%5.32M
480.57%3.45M
332.67%2.61M
6.46%975.03K
4.74%896.43K
-22.08%593.93K
-29.64%602.62K
-87.02%915.90K
-87.21%855.84K
-88.08%762.19K
-84.92%856.50K
-57.30%7.05M
-58.31%6.69M
Total equity
-50.76%3.03M
-95.82%356.74K
-77.91%2.21M
-55.13%4.85M
-57.63%6.14M
-14.72%8.53M
-22.10%9.99M
-12.94%10.80M
7.54%14.50M
-36.81%10.00M
-24.57%12.83M
-33.26%12.40M
-33.09%13.49M
-26.69%15.83M
448.50%17.00M
587.95%18.59M
848.10%20.16M
1722.01%21.60M
67.67%-4.88M
73.62%-3.81M
Cash Flow Statement
Net operating income
-37.03%-3.81M
-2.87%-2.42M
-70.70%-2.90M
-44.43%-2.69M
-19.89%-2.78M
-32.39%-2.35M
-44.10%-1.70M
-45.31%-1.87M
2.58%-2.32M
-9.76%-1.77M
18.75%-1.18M
-2.59%-1.28M
-49.21%-2.38M
-41.11%-1.62M
-130.65%-1.45M
-68.65%-1.25M
-95.97%-1.59M
-100.14%-1.15M
-20.32%-629.36K
-76.44%-741.83K
Net investment
-59.08%968.45K
56.64%2.40M
113.25%2.00M
-28.29%2.13M
148.03%2.37M
1422.47%1.53M
4485.96%936.75K
263.01%2.97M
-294.08%-4.93M
103.10%100.67K
99.78%-21.36K
694.91%819.03K
2417.33%2.54M
-10480.11%-3.24M
---9.91M
---137.67K
---109.57K
---30.66K
----
----
Net financing
306.40%4.44M
830.90%923.24K
---49.31K
7015.35%888.14K
-85.47%1.09M
-252.05%-126.32K
-100.00%0.00
-103.12%-12.84K
--7.52M
--83.07K
--1.85M
--411.70K
----
----
--0.00
--0.00
-100.00%0.00
508.91%21.07M
-100.00%0.00
-100.00%0.00

FAQs

What is the total revenue of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its total revenue reached 359.70K, with a year-on-year change of 401.00K.

What are the current assets of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its current assets were 3.14M, with a year-on-year change of -71.85.

What are the total assets of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its total assets of BioRestorative Therapies Inc were 4.08M, with a year-on-year change of -66.78.

What are the total liabilities of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its total liabilities of BioRestorative Therapies Inc were 3.72M, with a year-on-year change of -0.68.

What is the total equity of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its total equity of BioRestorative Therapies Inc was 356.74K, with a year-on-year change of -95.82.

What is the net operating income of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its net operating income of BioRestorative Therapies Inc was -15.65M, with a year-on-year change of -35.41.

What is the net investment of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its net investment of BioRestorative Therapies Inc was 8.90M, with a year-on-year change of 1629.25.

What is the net financing of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its net financing of BioRestorative Therapies Inc was 2.85M, with a year-on-year change of -61.31.

What is the Earnings Per Share (EPS) of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.58, with a year-on-year change of -36.93.

What is the net income of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its net income was -14.24M, with a year-on-year change of -58.61.

What is the net margin of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its net profit margin was -3959.40, with a year-on-year change of -76.82.

What is the gross margin of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its gross margin was 93.37, with a year-on-year change of 0.40.

What is the Return on Equity (ROE) of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its Return on Equity (ROE) was -321.48, with a year-on-year change of -231.31.

What is the Return on Assets (ROA) of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its Return on Assets (ROA) was -174.11, with a year-on-year change of -141.33.

What is the operating profit of BioRestorative Therapies Inc?

According to BioRestorative Therapies Inc's FY2025 earnings report, its operating profit was -15.65M, with a year-on-year change of -35.41.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy